- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02272309
Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function
April 23, 2024 updated by: Ulrich Mehnert
Study part 1 will consist of sensory evoked cortical potential (SEP) measurements of the lower urinary tract (LUT) in healthy subjects using different stimulation frequencies from 0.25 to 3Hz to find the most effective frequency in regard to acquisition time for reliable SEP response rates.
Study part 2 will consist of a series of consecutive SEP measurements in patients with LUT symptoms during low bladder volume and maximum cystometric capacity to assess reliability of measurements and influence of potential concomitant LUTS treatments.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stéphanie Van der Lely
- Phone Number: +41 44 510 72 16
- Email: stephanie.vanderlely@balgrist.ch
Study Locations
-
-
-
Zurich, Switzerland, 8008
- Universitätsklinik Balgrist
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
healthy volunteers:
- Written informed consent,
- good mental and physical health,
- age >18y,
Patients with LUTS and Patients with LUTS and treatment:
- Written informed consent,
- age >18y,
- prior urodynamic investigation,
- LUTS since >6months with or without detrusor overactivity
Exclusion Criteria:
healthy volunteers:
- any neurological or urological pathology,
- current pregnancy or lactation,
- urinary tract infection,
- hematuria,
- any previous pelvic or spine or craniocerebral surgery,
- any anatomical anomaly of the LUT or genitalia,
- any metabolic disease,
- any LUT malignancy,
- bladder capacity <150mL,
- SDV at 60mL;
Patients with LUTS and Patients with LUTS and treatment:
- current pregnancy or lactation,
- urinary tract infection,
- gross hematuria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy volunteers
|
|
Experimental: Patients with LUTS
|
|
Experimental: Patients with LUTS and treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
N1latency of LUT SEPs
Time Frame: 2-3 measurements within 4-16 weeks from first exam
|
2-3 measurements within 4-16 weeks from first exam
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
October 20, 2014
First Submitted That Met QC Criteria
October 21, 2014
First Posted (Estimated)
October 22, 2014
Study Record Updates
Last Update Posted (Actual)
April 24, 2024
Last Update Submitted That Met QC Criteria
April 23, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH_2013-0518/PB_2016-00498
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Urinary Tract Symptoms
-
The Royal College of Surgeons of EnglandUniversity College, LondonCompletedUncomplicated Lower Urinary Tract Symptoms
-
National Taiwan University HospitalUnknownDisorder of the Lower Urinary TractTaiwan
-
ProVerum MedicalNot yet recruitingBPH With Symptomatic Lower Urinary Tract Symptoms
-
Baylor Research InstituteForte MedicalCompletedLower Urinary Tract Symptoms | Lower Urinary Tract InfectionUnited States
-
Far Eastern Memorial HospitalCompletedPsychiatric Aspects in Women With Lower Urinary Tract SymptomsTaiwan
-
The University of Texas Medical Branch, GalvestonCompletedLower Urinary Tract Symptoms | Lower Gastrointestinal Tract Symptoms
-
Jagiellonian UniversityPiotr ChlostaCompletedTo Evaluate Lower Urinary Tract Symptoms (LUTS) in PolandPoland
-
San Carlo di Nancy HospitalLampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)CompletedBPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsItaly
-
Boston Scientific CorporationTerminatedBPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States, Australia
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknownPain | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States
Clinical Trials on EEG and EP measurement
-
State Budgetary Healthcare Institution, National...CompletedCOVID | EncephalopathyRussian Federation
-
Lawson Health Research InstituteRecruiting
-
University Hospital, GhentUniversity GhentRecruitingAnterior Cruciate Ligament Rupture | Injuries | ElectroencephalographyBelgium
-
Medical University of ViennaAustrian Science Fund (FWF)UnknownSleep Disorders, Circadian RhythmAustria
-
Maastricht University Medical CenterMaastricht UniversityUnknownTranscatheter Aortic Valve Replacement | Transcatheter Aortic Valve Implantation | Left Bundle Branch BlockNetherlands
-
University of OxfordOxford University Hospitals NHS TrustRecruitingDelirium | Cognitive Impairment | Postoperative Cognitive Dysfunction | Cognitive DeclineUnited Kingdom
-
Sunovion Respiratory Development Inc.Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assistance Publique Hopitaux De MarseilleCompleted
-
University Hospital, CaenCompleted